Patents by Inventor Lee Denson

Lee Denson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210355538
    Abstract: The present disclosure provides methods for assessing responsiveness or non-responsiveness to a therapeutic agent (e.g., steroid therapy, anti-TNF therapy or anti-integrin ?4?7 therapy) in ulcerative colitis (UC) subjects based on gene signatures. The methods may further comprise identifying suitable treatment for the patient based on the gene signatures.
    Type: Application
    Filed: October 18, 2019
    Publication date: November 18, 2021
    Inventor: Lee Denson
  • Patent number: 9541560
    Abstract: Disclosed are novel biomarkers and methods related to diagnostic tests for the detection and characterization of inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. In particular, the instant invention relates to novel biomarkers and methods of using such biomarkers to predict disease behavior and severity, to differentiate among disease types, and to optimize selection of treatment options in individuals suspected of having an inflammatory bowel disease.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: January 10, 2017
    Assignee: Children's Hospital Medical Center
    Inventors: Lee Denson, Bruce Colston Trapnel, Kanji Uchida
  • Publication number: 20150293113
    Abstract: Disclosed are novel biomarkers and methods related to diagnostic tests for the detection and characterization of inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis.
    Type: Application
    Filed: April 14, 2015
    Publication date: October 15, 2015
    Inventors: Lee Denson, Bruce Colston Trapnel, Kanji Uchida
  • Publication number: 20130273566
    Abstract: Disclosed are novel biomarkers and methods related to diagnostic tests for the detection and characterization of inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. In particular, the instant invention relates to novel biomarkers and methods of using such biomarkers to predict disease behavior and severity, to differentiate among disease types, and to optimize selection of treatment options in individuals suspected of having an inflammatory bowel disease.
    Type: Application
    Filed: May 24, 2011
    Publication date: October 17, 2013
    Inventors: Lee Denson, Bruce Colston Trapnell, Kanji Uchida